Bilargen (bilastine) 20mg tablets

Bilargen is a pharmaceutical product containing bilastine, used for the treatment of allergic rhinoconjunctivitis and urticaria. The active ingredient, bilastine, was originally developed in Spain by FAES Farma. In several international markets, particularly in Greece (as indicated by the Greek text on the box), it is commercialized through licensing agreements.

The Menarini Group, an Italian multinational pharmaceutical company, holds widespread rights for the distribution and marketing of bilastine under various brand names like Bilargen, Bilexten, or Bilaxten. Manufacturing often occurs at Menarini’s facilities in Italy or through local partners in the European Union to serve specific regional markets. The ultimate ownership lies with the Menarini Group, which remains a privately held company based in Florence, Italy.